Functional and Morphological Changes in Diabetic Macular Oedema: Baseline Correlations, and Changes with Pharmacological Treatments

Several pharmacologic agents are now available for the treatment of DMO including anti-VEGF agents [1-6] and corticosteroids [1-11]. The introduction and frequency of these treatments has coincided with the introduction of less invasive investigating and monitoring systems including OCT